ESR1 and ovarian carcinoma: A large consortia study by Sieh et al. examined the prognostic role of these receptors in more than 2900 patients with primary ovarian cancer, including over 1700 patients with HGSOC, and reported that estrogen receptor was expressed in >80% of HGSOC cases [26].